|
| Status |
Public on Aug 15, 2022 |
| Title |
EZH2 Catalytic Inhibition Prevents Urothelial Carcinoma Progression Through Immune Activation. |
| Organisms |
Homo sapiens; Mus musculus |
| Experiment type |
Expression profiling by high throughput sequencing
Genome binding/occupancy profiling by high throughput sequencing
|
| Summary |
This SuperSeries is composed of the SubSeries listed below.
|
| |
|
| Overall design |
Refer to individual Series
|
| |
|
| Citation(s) |
36197969 |
| |
| Submission date |
Jul 27, 2022 |
| Last update date |
Nov 02, 2022 |
| Contact name |
Joshua Meeks |
| Organization name |
Northwestern University
|
| Department |
Urology/BMG
|
| Street address |
302 E. Huron Street, Simpson Querrey Building, Room number: 7-500
|
| City |
Chicago |
| State/province |
Illinois |
| ZIP/Postal code |
60611 |
| Country |
USA |
| |
|
| Platforms (3) |
| GPL11154 |
Illumina HiSeq 2000 (Homo sapiens) |
| GPL13112 |
Illumina HiSeq 2000 (Mus musculus) |
| GPL18573 |
Illumina NextSeq 500 (Homo sapiens) |
|
| Samples (39)
|
|
| This SuperSeries is composed of the following SubSeries: |
| GSE209851 |
EZH2 Catalytic Inhibition Prevents Urothelial Carcinoma Progression Through Immune Activation [RNA-seq] |
| GSE209852 |
EZH2 Catalytic Inhibition Prevents Urothelial Carcinoma Progression Through Immune Activation [ChIP-seq] |
|
| Relations |
| BioProject |
PRJNA862706 |
Less...
More...